Latest news
Loading news…
Perfuse Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for ocular diseases.
Perfuse Therapeutics was acquired by Bayer in 2026 for $2B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
11
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- South San Francisco, California, United States
- Diversity spotlight
- Women Founded
Key People at Perfuse Therapeutics
Founder and CEO
11
professional contacts at Perfuse Therapeutics
Contact execs at Perfuse Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Perfuse Therapeutics
Loading news…
FAQs about Perfuse Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.